$59.2 Million is the total value of Telemetry Investments, L.L.C.'s 89 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 56.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KDMN | Sell | KADMON HLDGS INC | $1,506,000 | -10.6% | 362,837 | -15.6% | 2.54% | -30.5% |
| AFMD | Sell | AFFIMED N V | $918,000 | +0.1% | 157,653 | -41.7% | 1.55% | -22.1% |
| HGEN | Sell | HUMANIGEN INC | $831,000 | -44.9% | 47,489 | -66.5% | 1.40% | -57.1% |
| BLPH | Sell | BELLEROPHON THERAPEUTICS INC | $606,000 | -49.2% | 90,884 | -22.4% | 1.02% | -60.5% |
| MBIO | Sell | MUSTANG BIO INC | $564,000 | -20.1% | 149,000 | -33.5% | 0.95% | -37.9% |
| VRAY | Sell | VIEWRAY INC | $535,000 | +7.2% | 139,989 | -1.8% | 0.90% | -16.6% |
| GLD | Sell | SPDR GOLD TR | $535,000 | -32.9% | 3,000 | -33.3% | 0.90% | -47.8% |
| NEM | Sell | NEWMONT CORP | $443,000 | -9.4% | 7,401 | -3.9% | 0.75% | -29.5% |
| GSAT | Sell | GLOBALSTAR INC | $373,000 | +8.1% | 1,101,812 | -2.1% | 0.63% | -16.0% |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $371,000 | -52.4% | 106,009 | -67.4% | 0.63% | -63.0% |
| ACIA | Sell | ACACIA COMMUNICATIONS INC | $365,000 | -54.1% | 5,000 | -57.6% | 0.62% | -64.3% |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $303,000 | -55.9% | 46,800 | -82.5% | 0.51% | -65.7% |
| PCG | Sell | PG&E CORP | $284,000 | -36.3% | 22,800 | -52.0% | 0.48% | -50.5% |
| VSTM | Sell | VERASTEM INC | $224,000 | +15.5% | 105,000 | -34.4% | 0.38% | -10.4% |
| FE | Sell | FIRSTENERGY CORP | $223,000 | +2.3% | 7,300 | -3.9% | 0.38% | -20.5% |
| TCON | Sell | TRACON PHARMACEUTICALS INC | $120,000 | -57.6% | 10,223 | -81.3% | 0.20% | -67.0% |
| CDOR | Exit | CONDOR HOSPITALITY TR INC | $0 | – | -15,651 | -100.0% | -0.09% | – |
| ONDK | Exit | ON DECK CAP INC | $0 | – | -25,500 | -100.0% | -0.09% | – |
| INWK | Exit | INNERWORKINGS INC | $0 | – | -14,000 | -100.0% | -0.09% | – |
| GILT | Exit | GILAT SATELLITE NETWORKS LTD | $0 | – | -13,463 | -100.0% | -0.16% | – |
| FBIO | Exit | FORTRESS BIOTECH INC | $0 | – | -18,376 | -100.0% | -0.16% | – |
| HUD | Exit | HUDSON LTD | $0 | – | -10,000 | -100.0% | -0.16% | – |
| CETV | Exit | CENTRAL EUROPEAN MEDIA ENTRPcl a new | $0 | – | -20,000 | -100.0% | -0.18% | – |
| XTNT | Exit | XTANT MED HLDGS INC | $0 | – | -146,139 | -100.0% | -0.26% | – |
| BREW | Exit | CRAFT BREW ALLIANCE INC | $0 | – | -11,500 | -100.0% | -0.41% | – |
| AEM | Exit | AGNICO EAGLE MINES LTD | $0 | – | -2,700 | -100.0% | -0.47% | – |
| BMY | Exit | BRISTOL-MYERS SQUIBB CO | $0 | – | -3,800 | -100.0% | -0.50% | – |
| ADSW | Exit | ADVANCED DISP SVCS INC DEL | $0 | – | -9,010 | -100.0% | -0.59% | – |
| WMGI | Exit | WRIGHT MED GROUP N V | $0 | – | -11,455 | -100.0% | -0.76% | – |
| RST | Exit | ROSETTA STONE INC | $0 | – | -15,662 | -100.0% | -1.02% | – |
| AIMT | Exit | AIMMUNE THERAPEUTICS INC | $0 | – | -15,500 | -100.0% | -1.16% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -7,191 | -100.0% | -1.33% | – |
| DLPH | Exit | DELPHI TECHNOLOGIES PL | $0 | – | -55,384 | -100.0% | -2.01% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -18,500 | -100.0% | -2.11% | – |
| LVGO | Exit | LIVONGO HEALTH INC | $0 | – | -7,400 | -100.0% | -2.25% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -2,500 | -100.0% | -3.04% | – |
| ETFC | Exit | E TRADE FINANCIAL CORP | $0 | – | -35,500 | -100.0% | -3.86% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| RIGEL PHARMACEUTICALS INC | 33 | Q4 2022 | 1.7% |
| AFFIMED N V | 31 | Q4 2022 | 3.9% |
| GLOBALSTAR INC | 30 | Q4 2022 | 2.5% |
| VIEWRAY INC | 23 | Q4 2022 | 2.1% |
| SPDR GOLD TRUST | 22 | Q4 2022 | 2.3% |
| ADMA BIOLOGICS INC | 21 | Q4 2022 | 2.9% |
| STEMLINE THERAPEUTICS INC | 21 | Q1 2020 | 1.2% |
| SPDR S&P 500 ETF TR | 20 | Q4 2022 | 53.9% |
| KADMON HLDGS INC | 19 | Q2 2021 | 7.0% |
| EIGER BIOPHARMACEUTICALS INC | 19 | Q4 2022 | 6.7% |
View Telemetry Investments, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Xtant Medical Holdings, Inc. | February 13, 2020 | 752,915 | 5.7% |
| Orexigen Therapeutics, Inc. | February 14, 2019 | 1,295,844 | 6.4% |
| Xtant Medical Holdings, Inc. | February 14, 2018 | 1,416,339 | 7.2% |
View Telemetry Investments, L.L.C.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-17 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
View Telemetry Investments, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.